0
Abstract: Poster Presentations |

THORACOSCOPIC LUNG RESECTION FOR LUNG CANCER USING PREEMPTIVE ANALGESIA IN 80-YEAR-OLD PATIENTS FREE TO VIEW

Takashi Tojo, MD*; Michitaka Kimura, MD; Hiroshi Naito, MD; Yoko Nagata, MD; Norikazu Kawai, MD; Shigeki Taniguchi, MD
Author and Funding Information

Nara Medical University, Kashihara, Japan


Chest


Chest. 2008;134(4_MeetingAbstracts):p76003. doi:10.1378/chest.134.4_MeetingAbstracts.p76003
Text Size: A A A
Published online

Abstract

PURPOSE: Video-assisted thoracoscopic surgery has widely recognized as a less invasive surgical therapy for a lung cancer. The purpose of this study was to determine whether thoracoscopic lung resections for lung cancer using a pre-emptive analgesia would be performed safely and completely in over 80 year-old patients.

METHODS: From November 2000 to April 2008, 43 patients over 80 years old with non-small cell lung cancer have been thoracoscopically operated on using a pre-emptive analgesia. As a pre-emptive analgesia, we used pre-operative epidural anesthesia, and a intercostals nerve block and subcutaneous local anesthesia in the end of the operation. 43 patients, 80 to 88 years of age (mean 82.0), underwent 14 lobectomy (with a mediastinal lymphnode resection in 5), 7 segmentectomy, 22 wedge resection.

RESULTS: There is no operative mortality and all patients but two were alive (two patient died of cancer). Post-operative complications were few (atelectasis 2, air leakage 2). Visual analogue scales at post operative periods revealed low points (VAS in one Post Operative Day; 1.2 at rest, 2.2 at coughing 3, two POD; 1.5 at rest, 2.6 at coughing, seven POD; 0.7 at rest, 1.3 at coughing).

CONCLUSION: Video-assisted thoracoscopic lung resections using a pre-emptive analgesia for lung cancer patients over 80 years or more is considered to offer an acceptable clinical outcome.

CLINICAL IMPLICATIONS: Video-assisted thoracoscopic lung resections using a pre-emptive analgesia for lung cancer patients over 80 years or more is considered to offer an acceptable clinical outcome.

DISCLOSURE: Takashi Tojo, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, October 28, 2008

1:00 PM - 2:15 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543